天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Home Cart 0 Sign in  

[ CAS No. 1310584-14-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1310584-14-5
Chemical Structure| 1310584-14-5
Structure of 1310584-14-5 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 1310584-14-5 ]

Related Doc. of [ 1310584-14-5 ]

Alternatived Products of [ 1310584-14-5 ]
Product Citations

Product Citations

Ganga Reddy Velma ; Zhengnan Shen ; Cameron Holberg , et al. DOI: PubMed ID:

Abstract: The SARS-CoV-2 papain-like (PLpro), essential for viral processing and immune response disruption, is a promising target for treating acute infection of SARS-CoV-2. To date, there have been no reports of PLpro inhibitors with both submicromolar potency and animal model efficacy. To address the challenge of PLpro’s featureless active site, a noncovalent inhibitor library with over 50 new analogs was developed, targeting the PLpro active site by modulating the BL2-loop and engaging the BL2-groove. Notably, compounds 42 and 10 exhibited strong effects and were further analyzed pharmacokinetically. 10, in particular, showed a significant lung accumulation, up to 12.9-fold greater than plasma exposure, and was effective in a mouse model of SARS-CoV-2 infection, as well as against several SARS-CoV-2 variants. These findings highlight the potential of 10 as an in vivo chemical for studying PLpro inhibition in SARS-CoV-2 infection.

Purchased from AmBeed: ; ; ;

Product Details of [ 1310584-14-5 ]

CAS No. :1310584-14-5 MDL No. :MFCD20264878
Formula : C45H59ClNPPd Boiling Point : No data available
Linear Structure Formula :- InChI Key :-
M.W : 786.80 Pubchem ID :-
Synonyms :

Calculated chemistry of [ 1310584-14-5 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 49
Num. arom. heavy atoms : 24
Fraction Csp3 : 0.47
Num. rotatable bonds : 8
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 221.65
TPSA : 30.2 ?2

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -0.95 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 14.29
Log Po/w (WLOGP) : 12.62
Log Po/w (MLOGP) : 5.39
Log Po/w (SILICOS-IT) : 11.45
Consensus Log Po/w : 8.75

Druglikeness

Lipinski : 2.0
Ghose : None
Veber : 0.0
Egan : 1.0
Muegge : 2.0
Bioavailability Score : 0.17

Water Solubility

Log S (ESOL) : -13.56
Solubility : 0.0 mg/ml ; 0.0 mol/l
Class : Insoluble
Log S (Ali) : -15.01
Solubility : 0.0 mg/ml ; 9.68e-16 mol/l
Class : Insoluble
Log S (SILICOS-IT) : -15.86
Solubility : 0.0 mg/ml ; 1.38e-16 mol/l
Class : Insoluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 3.0
Synthetic accessibility : 7.3

Safety of [ 1310584-14-5 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P305+P351+P338 UN#:
Hazard Statements:H315-H319-H335 Packing Group:
GHS Pictogram:
Recommend Products
Same Skeleton Products

Technical Information

Historical Records
; ;